EP Patent

EP2623507A1 — Morpholino nucleic acid derivative

Assigned to Nippon Shinyaku Co Ltd · Expires 2013-08-07 · 13y expired

What this patent protects

The Present invention provides a useful morpholino nucleic acid derivative for synthesizing a morpholino nucleic acid oligomer. The present invention provides a compound represented by the following general formula (1) or a salt. wherein R 1 represents hydrogen, trityl an…

USPTO Abstract

The Present invention provides a useful morpholino nucleic acid derivative for synthesizing a morpholino nucleic acid oligomer. The present invention provides a compound represented by the following general formula (1) or a salt. wherein R 1 represents hydrogen, trityl and so on. R 2 represents amide or imine. R 3 represents a hydroxy group which may be protected by trialkylsilyl and so on, or a group represented by the following general formula (5). (wherein X represents O or S. Y represents dialkylamino or alkoxy. Z represents chlorine.)

Drugs covered by this patent

Patent Metadata

Patent number
EP2623507A1
Jurisdiction
EP
Classification
—
Expires
2013-08-07
Drug substance claim
No
Drug product claim
No
Assignee
Nippon Shinyaku Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.